Plancorp LLC Cuts Stock Position in Cigna Group $CI

Key Points

• Plancorp LLC has reduced its stake in Cigna Group by 30.4%, selling 831 shares and holding 1,907 shares valued at approximately $628,000.
• Cigna Group reported earnings of $7.20 per share for the last quarter, exceeding estimates and achieving a revenue growth of 11.0% year-over-year.
• The company has announced a quarterly dividend of $1.51 per share, representing an annual yield of 2.0%, with the dividend payout ratio at 32.97%.

Plancorp LLC reduced its position in Cigna Group (NYSE:CI - Free Report) by 30.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,907 shares of the health services provider's stock after selling 831 shares during the quarter. Plancorp LLC's holdings in Cigna Group were worth $628,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of CI. Nuveen LLC acquired a new position in Cigna Group in the 1st quarter valued at about $727,905,000. GAMMA Investing LLC grew its position in shares of Cigna Group by 58,799.0% during the first quarter. GAMMA Investing LLC now owns 1,774,626 shares of the health services provider's stock worth $583,852,000 after buying an additional 1,771,613 shares in the last quarter. Price T Rowe Associates Inc. MD grew its position in shares of Cigna Group by 10.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 12,056,806 shares of the health services provider's stock worth $3,966,690,000 after buying an additional 1,094,327 shares in the last quarter. GQG Partners LLC grew its position in shares of Cigna Group by 21.5% during the first quarter. GQG Partners LLC now owns 4,886,674 shares of the health services provider's stock worth $1,607,716,000 after buying an additional 865,092 shares in the last quarter. Finally, Two Sigma Advisers LP grew its position in shares of Cigna Group by 278.0% during the fourth quarter. Two Sigma Advisers LP now owns 816,200 shares of the health services provider's stock worth $225,385,000 after buying an additional 600,300 shares in the last quarter. 86.99% of the stock is owned by institutional investors and hedge funds.

Cigna Group Stock Down 0.4%

CI stock traded down $1.19 during trading on Friday, hitting $304.68. 434,302 shares of the company's stock were exchanged, compared to its average volume of 1,811,703. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.65. Cigna Group has a 52-week low of $256.89 and a 52-week high of $370.83. The business has a 50-day moving average price of $295.81 and a two-hundred day moving average price of $312.08. The stock has a market capitalization of $81.33 billion, a price-to-earnings ratio of 16.65, a PEG ratio of 0.89 and a beta of 0.48.

Cigna Group (NYSE:CI - Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The health services provider reported $7.20 earnings per share for the quarter, beating analysts' consensus estimates of $7.15 by $0.05. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The company had revenue of $67.13 billion during the quarter, compared to analysts' expectations of $62.61 billion. During the same quarter in the previous year, the business earned $6.72 earnings per share. The firm's revenue for the quarter was up 11.0% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, equities research analysts expect that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 18th. Shareholders of record on Thursday, September 4th will be paid a $1.51 dividend. The ex-dividend date is Thursday, September 4th. This represents a $6.04 dividend on an annualized basis and a yield of 2.0%. Cigna Group's payout ratio is currently 32.97%.

Insiders Place Their Bets

In other Cigna Group news, insider Nicole S. Jones sold 28,526 shares of the business's stock in a transaction that occurred on Friday, August 15th. The stock was sold at an average price of $300.00, for a total value of $8,557,800.00. Following the completion of the sale, the insider owned 25,648 shares in the company, valued at approximately $7,694,400. The trade was a 52.66% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.70% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts have recently commented on CI shares. Barclays boosted their price objective on Cigna Group from $354.00 to $383.00 and gave the stock an "overweight" rating in a research report on Thursday, September 4th. Wells Fargo & Company lowered their price objective on Cigna Group from $341.00 to $340.00 and set an "equal weight" rating for the company in a research report on Thursday, August 14th. Wall Street Zen downgraded Cigna Group from a "buy" rating to a "hold" rating in a research report on Saturday, August 2nd. Truist Financial set a $375.00 target price on Cigna Group in a research note on Tuesday, September 2nd. Finally, TD Cowen upgraded Cigna Group to a "strong-buy" rating in a research note on Monday, June 23rd. Two research analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have assigned a Hold rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Buy" and a consensus price target of $374.76.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.